Cargando…
Cluster headache: new targets and options for treatment
Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
F1000 Research Limited
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861507/ https://www.ncbi.nlm.nih.gov/pubmed/29623198 http://dx.doi.org/10.12688/f1000research.13380.1 |
_version_ | 1783308109227229184 |
---|---|
author | Doesborg, Patty Haan, Joost |
author_facet | Doesborg, Patty Haan, Joost |
author_sort | Doesborg, Patty |
collection | PubMed |
description | Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible treatment options are emerging. Calcitonin gene-related peptide (CGRP)-targeted medication could become the first (cluster) headache-specific treatment option. Other exciting new treatment options include invasive and non-invasive neuromodulation techniques. Here, we provide a short overview of new targets and treatment options that are being investigated for cluster headache. |
format | Online Article Text |
id | pubmed-5861507 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2018 |
publisher | F1000 Research Limited |
record_format | MEDLINE/PubMed |
spelling | pubmed-58615072018-04-04 Cluster headache: new targets and options for treatment Doesborg, Patty Haan, Joost F1000Res Review Cluster headache is a severe headache disorder with considerable impact on quality of life. The pathophysiology of the disease remains poorly understood. With few specific targets for treatment, current guidelines mainly include off-label treatment with medication. However, new targets for possible treatment options are emerging. Calcitonin gene-related peptide (CGRP)-targeted medication could become the first (cluster) headache-specific treatment option. Other exciting new treatment options include invasive and non-invasive neuromodulation techniques. Here, we provide a short overview of new targets and treatment options that are being investigated for cluster headache. F1000 Research Limited 2018-03-20 /pmc/articles/PMC5861507/ /pubmed/29623198 http://dx.doi.org/10.12688/f1000research.13380.1 Text en Copyright: © 2018 Doesborg P and Haan J http://creativecommons.org/licenses/by/4.0/ This is an open access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Review Doesborg, Patty Haan, Joost Cluster headache: new targets and options for treatment |
title | Cluster headache: new targets and options for treatment |
title_full | Cluster headache: new targets and options for treatment |
title_fullStr | Cluster headache: new targets and options for treatment |
title_full_unstemmed | Cluster headache: new targets and options for treatment |
title_short | Cluster headache: new targets and options for treatment |
title_sort | cluster headache: new targets and options for treatment |
topic | Review |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5861507/ https://www.ncbi.nlm.nih.gov/pubmed/29623198 http://dx.doi.org/10.12688/f1000research.13380.1 |
work_keys_str_mv | AT doesborgpatty clusterheadachenewtargetsandoptionsfortreatment AT haanjoost clusterheadachenewtargetsandoptionsfortreatment |